S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.48 (-0.18%)
AAPL   189.17 (-0.65%)
MSFT   378.81 (-1.02%)
META   332.64 (-1.87%)
GOOGL   134.91 (-1.67%)
AMZN   146.36 (-0.46%)
TSLA   243.15 (-1.45%)
NVDA   480.91 (+0.56%)
NIO   7.14 (-0.97%)
BABA   74.74 (-2.61%)
AMD   123.51 (+1.23%)
T   16.26 (+0.49%)
F   10.58 (+2.03%)
MU   76.39 (+0.35%)
CGC   0.56 (+3.31%)
GE   118.49 (-0.30%)
DIS   92.45 (-0.05%)
AMC   7.09 (+5.82%)
PFE   30.07 (+1.28%)
PYPL   57.98 (-0.84%)
XOM   101.99 (-1.84%)
S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.48 (-0.18%)
AAPL   189.17 (-0.65%)
MSFT   378.81 (-1.02%)
META   332.64 (-1.87%)
GOOGL   134.91 (-1.67%)
AMZN   146.36 (-0.46%)
TSLA   243.15 (-1.45%)
NVDA   480.91 (+0.56%)
NIO   7.14 (-0.97%)
BABA   74.74 (-2.61%)
AMD   123.51 (+1.23%)
T   16.26 (+0.49%)
F   10.58 (+2.03%)
MU   76.39 (+0.35%)
CGC   0.56 (+3.31%)
GE   118.49 (-0.30%)
DIS   92.45 (-0.05%)
AMC   7.09 (+5.82%)
PFE   30.07 (+1.28%)
PYPL   57.98 (-0.84%)
XOM   101.99 (-1.84%)
S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.48 (-0.18%)
AAPL   189.17 (-0.65%)
MSFT   378.81 (-1.02%)
META   332.64 (-1.87%)
GOOGL   134.91 (-1.67%)
AMZN   146.36 (-0.46%)
TSLA   243.15 (-1.45%)
NVDA   480.91 (+0.56%)
NIO   7.14 (-0.97%)
BABA   74.74 (-2.61%)
AMD   123.51 (+1.23%)
T   16.26 (+0.49%)
F   10.58 (+2.03%)
MU   76.39 (+0.35%)
CGC   0.56 (+3.31%)
GE   118.49 (-0.30%)
DIS   92.45 (-0.05%)
AMC   7.09 (+5.82%)
PFE   30.07 (+1.28%)
PYPL   57.98 (-0.84%)
XOM   101.99 (-1.84%)
S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.48 (-0.18%)
AAPL   189.17 (-0.65%)
MSFT   378.81 (-1.02%)
META   332.64 (-1.87%)
GOOGL   134.91 (-1.67%)
AMZN   146.36 (-0.46%)
TSLA   243.15 (-1.45%)
NVDA   480.91 (+0.56%)
NIO   7.14 (-0.97%)
BABA   74.74 (-2.61%)
AMD   123.51 (+1.23%)
T   16.26 (+0.49%)
F   10.58 (+2.03%)
MU   76.39 (+0.35%)
CGC   0.56 (+3.31%)
GE   118.49 (-0.30%)
DIS   92.45 (-0.05%)
AMC   7.09 (+5.82%)
PFE   30.07 (+1.28%)
PYPL   57.98 (-0.84%)
XOM   101.99 (-1.84%)

Nutrien Stock Price, News & Analysis (NYSE:NTR)

$55.47
+0.06 (+0.11%)
(As of 03:45 PM ET)
Compare
Today's Range
$55.08
$55.81
50-Day Range
$53.10
$62.93
52-Week Range
$52.23
$85.16
Volume
705,811 shs
Average Volume
2.18 million shs
Market Capitalization
$27.43 billion
P/E Ratio
12.81
Dividend Yield
3.82%
Price Target
$77.65

Nutrien MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
40.1% Upside
$77.65 Price Target
Short Interest
Healthy
1.03% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-5.10
Upright™ Environmental Score
News Sentiment
1.14mentions of Nutrien in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-3.53%
From $5.39 to $5.20 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.92 out of 5 stars

Basic Materials Sector

14th out of 165 stocks

Agricultural Chemicals Industry

1st out of 9 stocks


NTR stock logo

About Nutrien Stock (NYSE:NTR)

Nutrien Ltd. provides crop inputs and services. The company operates through Retail, Potash, Nitrogen, and Phosphate segments. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products. The Nitrogen segment offers ammonia, urea, urea ammonium nitrate, industrial grade ammonium nitrate, and ammonium sulfate. The Phosphate segment provides solid fertilizer, liquid fertilizer, and industrial and feed products. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.

NTR Stock Price History

NTR Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Nutrien Stock (NYSE:NTR) Insider Trades
Nutrien (NYSE:NTR) Price Target Cut to $68.00
How Nourishing Is Nutrien Ltd. for Your Growing Portfolio?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Nutrien 2024 consensus estimates high - JPMorgan
Nutrien Ltd. (NYSE:NTR) Q3 2023 Earnings Call Transcript
Nutrien's (NTR) Q3 Earnings and Revenues Miss Estimates
Nutrien Reports Third Quarter 2023 Results
Nutrien: Q3 Earnings Snapshot
Amazon revenue jumps 13%
Nutrien (NTR) Stock Sinks As Market Gains: Here's Why
Is Nutrien Stock a Buy?
See More Headlines
Receive NTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/13 Dividend
9/28/2023
Dividend Payable
10/13/2023
Last Earnings
11/01/2023
Today
11/29/2023
Ex-Dividend for 1/12 Dividend
12/28/2023
Fiscal Year End
12/31/2023
Dividend Payable
1/12/2024
Next Earnings (Estimated)
2/21/2024

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Employees
24,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$77.65
High Stock Price Target
$106.00
Low Stock Price Target
$58.00
Potential Upside/Downside
+40.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
18 Analysts

Profitability

Net Income
$7.66 billion
Pretax Margin
10.81%

Debt

Sales & Book Value

Annual Sales
$37.88 billion
Cash Flow
$18.11 per share
Book Value
$50.95 per share

Miscellaneous

Free Float
479,265,000
Market Cap
$27.40 billion
Optionable
Optionable
Beta
0.94

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Kenneth A. SeitzMr. Kenneth A. Seitz (Age 53)
    President, CEO & Director
    Comp: $2.25M
  • Mr. Pedro FarahMr. Pedro Farah
    Executive VP & CFO
  • Ms. Noralee M. Bradley LLB.
    Executive VP of External Affairs and Chief Sustainability & Legal Officer
  • Mr. Mark Thompson
    Executive VP & Chief Commercial Officer
  • Mr. Jeffrey Martin Tarsi
    Executive VP & President of Global Retail
  • Jeff Holzman
    Vice President of Investor Relations
  • Megan Fielding
    VP of Brand & Culture Communications
  • Andy Kelemen
    Executive VP and Chief of Corporate Development & Strategy Officer
  • Jason Newton
    Head Economist
  • Mr. Trevor Williams
    Executive VP and President of Nitrogen & Phosphate

Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Nutrien was last updated on Thursday, November 16, 2023 at 12:00 AM.

Pros

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • Nutrien Ltd. provides crop inputs and services, operating through various segments such as Retail, Potash, Nitrogen, and Phosphate. This diversified business model allows for multiple revenue streams and potential growth opportunities.
  • The company has a strong retail network of farm centers in North America, South America, and Australia. This extensive distribution network provides Nutrien Ltd. with a wide customer base and market reach.
  • Nutrien Ltd. is a relatively new company, incorporated in 2017. This means that it has the potential for further growth and expansion as it continues to establish itself in the market.

Cons

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • The stock price of Nutrien Ltd. is subject to market fluctuations and can be influenced by various factors such as economic conditions, commodity prices, and industry trends. Investors should carefully consider these factors before making investment decisions.














NTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Nutrien stock right now?

18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NTR shares.
View NTR analyst ratings
or view top-rated stocks.

What is Nutrien's stock price target for 2024?

18 brokers have issued 12-month price targets for Nutrien's stock. Their NTR share price targets range from $58.00 to $106.00. On average, they expect the company's share price to reach $77.65 in the next year. This suggests a possible upside of 39.7% from the stock's current price.
View analysts price targets for NTR
or view top-rated stocks among Wall Street analysts.

How have NTR shares performed in 2023?

Nutrien's stock was trading at $73.03 on January 1st, 2023. Since then, NTR stock has decreased by 23.9% and is now trading at $55.58.
View the best growth stocks for 2023 here
.

When is Nutrien's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 21st 2024.
View our NTR earnings forecast
.

How were Nutrien's earnings last quarter?

Nutrien Ltd. (NYSE:NTR) issued its quarterly earnings results on Wednesday, November, 1st. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by $0.36. The business earned $5.63 billion during the quarter, compared to analyst estimates of $5.69 billion. Nutrien had a net margin of 7.11% and a trailing twelve-month return on equity of 11.93%. The business's quarterly revenue was down 31.2% compared to the same quarter last year. During the same quarter last year, the business earned $2.51 earnings per share.

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien declared a quarterly dividend on Wednesday, November 1st. Investors of record on Friday, December 29th will be given a dividend of $0.53 per share on Friday, January 12th. This represents a $2.12 dividend on an annualized basis and a yield of 3.81%. The ex-dividend date is Thursday, December 28th.
Read our dividend analysis for NTR
.

Is Nutrien a good dividend stock?

Nutrien (NYSE:NTR) pays an annual dividend of $2.12 per share and currently has a dividend yield of 3.85%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 48.96%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NTR will have a dividend payout ratio of 40.77% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NTR.

What guidance has Nutrien issued on next quarter's earnings?

Nutrien updated its FY23 earnings guidance on Wednesday, November, 1st. The company provided earnings per share (EPS) guidance of $4.15-$5.00 for the period, compared to the consensus estimate of $5.21.

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Who are Nutrien's major shareholders?

Nutrien's stock is owned by a variety of retail and institutional investors. Top institutional investors include Deutsche Bank AG (2.97%), Deutsche Bank AG (2.97%), Mackenzie Financial Corp (2.65%), Parnassus Investments LLC (2.03%), First Eagle Investment Management LLC (1.87%) and TD Asset Management Inc (1.45%).

How do I buy shares of Nutrien?

Shares of NTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:NTR) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -